[go: up one dir, main page]

AR029829A1 - Uso de un derivado de la caseina para la preparacion de composiciones cosmeticas, farmaceuticas y veterinarias y las composiciones asi preparadas, utiles para inhibir la adhesion de la flora patogenica a la piel - Google Patents

Uso de un derivado de la caseina para la preparacion de composiciones cosmeticas, farmaceuticas y veterinarias y las composiciones asi preparadas, utiles para inhibir la adhesion de la flora patogenica a la piel

Info

Publication number
AR029829A1
AR029829A1 ARP010103356A ARP010103356A AR029829A1 AR 029829 A1 AR029829 A1 AR 029829A1 AR P010103356 A ARP010103356 A AR P010103356A AR P010103356 A ARP010103356 A AR P010103356A AR 029829 A1 AR029829 A1 AR 029829A1
Authority
AR
Argentina
Prior art keywords
compositions
cosmetic
pharmaceutical
preparation
derivative
Prior art date
Application number
ARP010103356A
Other languages
English (en)
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8169257&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR029829(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of AR029829A1 publication Critical patent/AR029829A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/986—Milk; Derivatives thereof, e.g. butter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Uso de un derivado de caseína para la preparacion de una composicion para uso cosmético, farmacéutico o veterinario, propuesta para ser administrada a humanos o animales con el proposito de prevenir o tratar trastornos inducidos por lo agentes patogenos del sistema cutáneo. También se describen las composiciones farmacéuticas, cosméticas y veterinarias así preparadas.
ARP010103356A 2000-07-14 2001-07-13 Uso de un derivado de la caseina para la preparacion de composiciones cosmeticas, farmaceuticas y veterinarias y las composiciones asi preparadas, utiles para inhibir la adhesion de la flora patogenica a la piel AR029829A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00115274 2000-07-14

Publications (1)

Publication Number Publication Date
AR029829A1 true AR029829A1 (es) 2003-07-16

Family

ID=8169257

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010103356A AR029829A1 (es) 2000-07-14 2001-07-13 Uso de un derivado de la caseina para la preparacion de composiciones cosmeticas, farmaceuticas y veterinarias y las composiciones asi preparadas, utiles para inhibir la adhesion de la flora patogenica a la piel

Country Status (14)

Country Link
US (1) US20030161850A1 (es)
EP (1) EP1303295B1 (es)
JP (1) JP2004503597A (es)
AR (1) AR029829A1 (es)
AT (1) ATE339217T1 (es)
AU (1) AU2001287560A1 (es)
CA (1) CA2415918C (es)
DE (1) DE60123067T2 (es)
DK (1) DK1303295T3 (es)
ES (1) ES2272535T3 (es)
PE (1) PE20020147A1 (es)
PT (1) PT1303295E (es)
UY (1) UY26835A1 (es)
WO (1) WO2002005839A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
US7332179B2 (en) 2003-12-12 2008-02-19 Kimberly-Clark Worldwide, Inc. Tissue products comprising a cleansing composition
US7642395B2 (en) 2004-12-28 2010-01-05 Kimberly-Clark Worldwide, Inc. Composition and wipe for reducing viscosity of viscoelastic bodily fluids
CA2699170A1 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
WO2011132191A1 (en) 2010-04-21 2011-10-27 Mileutis Ltd. Casein peptide for use in the treatment of uterine infections

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7786M (es) * 1968-10-07 1970-03-23
FR8087M (es) * 1968-10-08 1970-07-20
US3764670A (en) * 1970-10-28 1973-10-09 Ministry Of Agriculture Polypeptidic anti-biotic substances derived from casein
DE3049038A1 (de) * 1980-12-24 1982-07-15 Marie 8000 München Hauck Mittel zur bekaempfung von hautkrankheiten
US4525351A (en) * 1983-01-11 1985-06-25 Chr. Hansen's Laboratory, Inc. Liquid adherent disinfectant compositions for topical application and method of preparation
CA1249968A (en) * 1984-04-05 1989-02-14 Kazuo Kigasawa Ointment base
CH671879A5 (es) * 1987-02-26 1989-10-13 Nestle Sa
JP2631470B2 (ja) * 1987-05-15 1997-07-16 雪印乳業株式会社 感染防御剤
US5681586A (en) * 1989-03-23 1997-10-28 Gordon; Arthur L. Enzyme-modified soy and soy/casein combination healing compositions
US5166132A (en) * 1989-03-23 1992-11-24 Gordon Arthur L Healing composition employing an enzyme-modified casein
JP2673320B2 (ja) * 1990-01-25 1997-11-05 雪印乳業株式会社 う蝕原菌付着阻止剤
FR2657525B1 (fr) * 1990-01-26 1994-07-29 Dubois Jacques Produits dermo-cosmetiques nouveaux pour le nettoyage et le soin de la peau et/ou des cheveux.
EP0760673A1 (en) * 1994-05-26 1997-03-12 Abbott Laboratories INHIBITION OF ATTACHMENT OF $i(H. INFLUENZAE) TO HUMAN CELLS
WO1998046240A1 (en) * 1997-04-15 1998-10-22 Advanced Viral Research Corp. Topical treatment of skin diseases and eye afflictions

Also Published As

Publication number Publication date
EP1303295A1 (en) 2003-04-23
JP2004503597A (ja) 2004-02-05
DK1303295T3 (da) 2007-01-02
US20030161850A1 (en) 2003-08-28
EP1303295B1 (en) 2006-09-13
PE20020147A1 (es) 2002-02-26
DE60123067D1 (de) 2006-10-26
CA2415918A1 (en) 2002-01-24
ATE339217T1 (de) 2006-10-15
DE60123067T2 (de) 2007-04-12
UY26835A1 (es) 2002-01-31
ES2272535T3 (es) 2007-05-01
WO2002005839A1 (en) 2002-01-24
PT1303295E (pt) 2007-01-31
CA2415918C (en) 2010-06-01
AU2001287560A1 (en) 2002-01-30

Similar Documents

Publication Publication Date Title
AR030068A1 (es) Composiciones farmaceuticas para el tratamiento de condiciones dolorosas, inflamatorias y ulcerosas de superficies epiteliales humedas como por ejemplo mucositis, estomatitis y sindrome de behcet
ATE401089T1 (de) Orale zubereitungen, die antimikrobielle wirkstoffe enthalten zur prävention von systemischen erkrankungen
MX9604208A (es) Gel para el tratamiento de enfermedades de la piely para la desinfeccion de la piel.
BR0107246A (pt) Agentes diazabicìclicos ativos no sistema nervoso central
HUP0303840A2 (hu) Dermálisan alkalmazható folyékony készítmények állatokon élősködő rovarok leküzdésére
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
EP1100522A4 (en) ADMINISTRATION OF ACTIVE AGENTS OVER THE LUNG
ES2146300T3 (es) Utilizacion de composiciones antihelminticas para el tratamiento de infecciones causadas por anoplocephala perfoliata en equidos.
AR021074A1 (es) COMPOSICIoN FARMACÉUTICA DE MOXIFLOXACINA, PROCEDIMIENTO PARA SU PRODUCCIoN, Y USO DE DICHA COMPOSICIoN PARA PREPARAR UN MEDICAMENTO ANTIBACTERIANO.
ES2156603T3 (es) Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina.
BR9702309A (pt) Uso composição cosmética ou farmacêutica e processo de tratamento cosmético
ATE452640T1 (de) Mittel für erkrankungen assoziert mit knochensubstanzverlust
ECSP941122A (es) Derivados de 5-arilindoles
PA8452001A1 (es) Derivados de macrolidos c-4" sustituidos
BR0314511A (pt) Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater
AR098251A2 (es) Uso de aivlosin o de una sal de adición ácida del mismo farmacológicamente aceptada para la preparación de un medicamento de uso veterinario, un alimento para aves de corral o cerdos, una composición recubierta estable para ser agregada a dicho alimento y un medicamento de uso veterinario
AR022293A1 (es) Procedimiento de aplicacion de 3-(2,4,6-trimetilfenil)-4-neopentilcarboniloxi-5,5-tetrametilen-delta3-dihidrofuran-2-ona para la lucha contra la mosca blanca
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
AR000357A1 (es) Utilización de un antagonista de sustancia p para la preparación de una composición farmacéutica de aplicación topica para tratar las manchas rojas cutaneas de origen neurogeno y especialmente la rosacea y el eritema pudico
AR029829A1 (es) Uso de un derivado de la caseina para la preparacion de composiciones cosmeticas, farmaceuticas y veterinarias y las composiciones asi preparadas, utiles para inhibir la adhesion de la flora patogenica a la piel
AR024232A1 (es) Bromhidrato de eletriptan monohidratado, composicion farmaceutica, su uso en la preparacion de medicamentos y procedimiento para su preparacion
IT1250672B (it) Formulazioni orali di ubidecarenone in soluzione acquosa
ES2176786T3 (es) Uso de extractos de ginkgo biloba para la preparacion de composicionesfarmaceuticas.
HRP20050342B1 (hr) Farmaceutska formulacija olanzapina

Legal Events

Date Code Title Description
FB Suspension of granting procedure